Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Philippines Pharmaceutical Market Value to Reach $8 Billion by 2020

May 27, 2014

The Philippines pharmaceutical market value is expected to increase from approximately $4.3 billion in 2013 to $8 billion by 2020.

Avantor Performance Materials Names New CEO

May 27, 2014

Avantor Performance Materials appoints Michael Stubblefield as CEO.

FDA Targets Illegal Online Pharmacies

May 27, 2014

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

GSK Announces Vaccine Price Freeze in Support of GAVI Alliance

May 27, 2014

GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.

GE Healthcare Launches Xuri IL-2 Growth Factor

May 23, 2014

GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.

Selexys Pharmaceuticals Signs CMO Agreement with Cytovance Biologics

May 22, 2014

Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.

More Than 100 New Medicines in Development to Treat Mental Health Disorders

May 22, 2014

PhRMA announces 119 new medicines are in development to treat mental and addictive disorders.

Brookfield Marks 80 Years of Laboratory Technology

May 22, 2014

Brookfield continues to supply viscometers and rheometers for laboratory and on-line process control applications.

Kymab Receives $40 Million Investment From Gates Foundation and Wellcome Trust

May 22, 2014

Kymab receives $40 million investment for clinical development of antibody therapeutics.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here